Global Toxoplasmosis Diagnostic Testing Market: Snapshot
Toxoplasmosis is a disease that is caused due to infection by the parasite Toxoplasma gondii, one of the world’s most common parasites. Toxoplasmosis is caused because of consumption of improperly cooked pork, goat, mutton, or beef. It is also caused due to transfer of Toxoplasma gondii parasite via contaminated food, open wounds, or dust contaminated with cat feces.
Toxoplasma gondii parasite is found in bladder, kidneys, and intestines of infected persons. The parasite can also be transmitted from a pregnant woman to the developing fetus via the placenta. The seriousness of toxoplasmosis depends on the stage of pregnancy at which the infection is acquired. The transmission of infection to the developing fetus results in spontaneous abortion or premature birth.
Toxoplasmosis displays mild symptoms such as swelling in the lymph nodes and discomfort. Howbeit, toxoplasmosis infection in in HIV/AIDS cam result in serious life threatening condition. Toxoplasmosis can be severe or fatal in developing fetus, newborns, and individuals with weak immune systems.
At present, immunoperoxidase stain and serology polymerase chain reaction are commonly used diagnostic tests for toxoplasmosis. Serology is employed to measure immunoglobulin G in infected persons. Toxoplasmosis testing involves a blood test to examine the availability of antibodies for T.godii. Toxoplasmosis diagnostic testing is generally offered at hospitals, public or private laboratories, and physician offices.
North America is currently the leading regional market for toxoplasmosis diagnostic testing. This is mainly because of rising prevalence of infectious diseases and high awareness among individuals about the availability of advanced diagnostic techniques. Europe ranks second among the key regions for toxoplasmosis diagnostic testing. However, Asia Pacific is anticipated to emerge as a significant market for toxoplasmosis diagnostic testing in the upcoming years owing to modernization of healthcare infrastructure in emerging economies.
Toxoplasmosis is an infectious disease caused by protozoan parasite Toxoplasma gondii, one of the world’s most dreaded parasite. There are 3 major genotypes of Toxoplasma gondii, namely (type 1, type 2, and type 3). These genotypes differ in their pathogenicity and prevalence among people around the world. Toxoplasmosis may be caused by transmission of T.gondii parasite through open wounds, consumption of contaminated raw meat, mutton, pork, beef, or by transfusion of blood, and organ transplant. Healthy people usually exhibit flu like symptoms such as fever, fatigue, swollen lymph nodes, and headaches. People with a weak immune system augmented by conditions such as HIV/AIDS, are more likely to develop severe infections form the parasite. Toxoplasmosis can transmit transplacentally from mother to fetus if the mother becomes infected with toxoplasmosis during or just before pregnancy. The above mentioned condition may result into a miscarriage, a stillborn child, or with symptoms of toxoplasmosis. Diagnosis of Toxoplasmosis can be established by toxoplasmosis serologic profile (TSP) tests which include dye test (gold standard), indirect immune fluorescent test (IFAT), modified agglutination test (MAT), enzyme-linked immunosorbent assay (ELISA),immunoglobulin tests (IgG, IgM, and IgE antibodies tests). Other test comes under TSP test includes amplification of specific nucleic acid sequences (i.e. PCR), histological diagnosis, and isolation of T.gondii parasite. In infant diagnosis can be performed by procedures such as amniocentesis, and ultrasound scan. Diagnosis can also be made by direct observation of the parasite in stained tissue sections, cerebrospinal fluids (CSF), and blood, but these procedures are less frequently used because of difficulty in obtaining samples.
Geographically toxoplasmosis diagnostic testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Currently North America dominates the toxoplasmosis diagnostic testing market, followed by Europe. In the U.S. and Europe, type 2 genotype is more prevalent among people than the other two species. Rising incidences of chronic diseases, along with major consumption of meat, pork, beef, and mutton, has resulted in increasing demand for effective testing methods for T.gondii by diagnostics laboratories in these regions. Technological advancement would also boost the market demand for Toxoplasmosis diagnostic testing in the North America and Europe. By 2018, Asia Pacific region is expected to grow at fastest rate, owing to the large population base in the region, increasing incidences of chronic diseases, rising demand for technologically advanced diagnostic devices, region’s growing healthcare infrastructure, combined with government initiatives in providing better healthcare facilities.
Technological advancements in toxoplasmosis diagnostic testing such as touch down-multiplex PCR, increasing number of anti-infective drugs, and improving healthcare infrastructure around the world are some of the key drivers for the growth of toxoplasmosis diagnostic testing market. However, high cost of toxoplasmosis tests, and lack of awareness about the parasitic infection are some of the restraints in toxoplasmosis diagnostic testing market growth. Improving safety and quality of toxoplasmosis diagnostic devices, improving healthc artte infrastructure focus on the emerging markets (China and India), and providing low cost devices, would act as a new opportunities for players in the global toxoplasmosis diagnostic testing market. On the basis of end – users, the toxoplasmosis diagnostic testing market has been segmented into hospitals, pathology laboratories, clinics, and diagnostic centers.
The major players in toxoplasmosis diagnostic testing market are Abbott Laboratories, Bio-Rad Laboratories, Inc. Affymetrix, Inc., and Beckman Coulter, Inc. Other players having presence in the toxoplasmosis diagnostic testing market includes Biotest Biomerica, Inc., Cepheid, Inc., and GenBio.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
The study is a source of reliable data on:
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
- Middle East and Africa (GCC, Southern Africa, North Africa)
TMR estimates the market size of various sectors using a combination of available data on the number and revenue of companies within each sub-sector and tiers of companies. The basic components used to determine market size and forecast for a specific product area are not only limited to supply-side data, but are also related to demand, industry trends, and the economic outlook. All the above data points are utilized to generate a statistical model targeting the sector marketplace. More than 300 TMR analysts across the world integrate these elements into a framework to determine the subsector market size for a base year and then forecast growth within each market.
TMR regularly interviews technology and business professionals as an ongoing effort to track the latest developments within each sector. These continuous surveys are stratified by company size and industry segment and weighted to reflect the global market place. All data are collected on an ongoing effort through a structured questionnaire rolled over the web or conducted via telephones. This provides the TMR team opportunities to request for detailed question sets, complex skip patterns, and real-time calculations, which assists respondents in answering questions involving numbers and percentages. Respondents, who are interviewed as experts, are screened and qualified based on certain criteria in addition to their decision-making authority and the scope of activity within their organizations.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.